
Oflamk MZ Oral Suspension Mango
Marketer
MK Healthcare
Salt Composition
Ofloxacin (50mg) + Metronidazole (120mg) + Simethicone (10mg)
Overview Oflamk MZ Oral Suspension Mango
Pediatric patients receive Oflamk MZ Oral Suspension Mango, a mango-flavored liquid medication, to combat bacterial infections affecting the teeth, lungs, gastrointestinal system, urinary tract, and reproductive organs. It's also used empirically against bloody diarrhea and severe infections such as peritonitis. Administer this suspension orally to your child, ideally at the same time each day, either before or after meals; if stomach upset occurs, give it with food. The usual dosage is twice daily, morning and evening. If vomiting happens within 30 minutes of administration, repeat the dose, but avoid doubling if the next dose is due. Strictly adhere to the prescribed dosage, timing, and method, as these are tailored to the infection's nature and severity, your child's age, and weight. Minor, transient side effects such as nausea, vomiting, weight loss, metallic taste, headache, appetite changes, abdominal discomfort, and mild rashes may occur, typically resolving with continued use. However, persistent or bothersome side effects warrant immediate consultation with your child's physician. Provide your child's doctor with a complete medical history, including any allergies, heart conditions, liver problems, or kidney issues, as this information is vital for dosage adjustments and comprehensive treatment planning.
Uses of Oflamk MZ Oral Suspension Mango
Managing bacterial infections
Major Benefits of Oflamk MZ Oral Suspension Mango:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Oflamk MZ Mango Flavored Oral Suspension can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Oflamk MZ Oral Suspension Mango:
- Vomiting
- Nausea
- Weight loss
- Abdominal pain
- Headache
- Diarrhea
- Loss of appetite
- Dizziness
- Insomnia (difficulty in sleeping)
- Metallic taste
- Urine discoloration
How to use Oflamk MZ Oral Suspension Mango:
Administer this medication precisely as prescribed by your physician, adhering to the dosage and treatment schedule. Consult the product label for detailed instructions prior to ingestion. Use a measuring device for accurate dosing and consume orally. Ensure thorough shaking before each use. Oflamk MZ Mango-flavored Oral Suspension can be ingested with or without food; however, consistent daily timing is recommended.
How Oflamk MZ Oral Suspension Mango works:
Oflamk MZ Mango-flavored oral suspension unites three active components. Two, ofloxacin and metronidazole, are antibiotics that disrupt bacterial DNA replication, thus eliminating infection-causing bacteria and halting infection spread. The third, simethicone, a gas-absorbing agent, enhances the formulation's digestibility. It achieves this by binding to gas pockets, whether produced by the antibiotics or other sources, facilitating gas expulsion and relieving associated abdominal discomfort and distension.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Oflamk MZ Mango-flavored oral suspension cautiously. A modified dosage of Oflamk MZ Mango-flavored oral suspension may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Oflamk MZ Oral Suspension Mango cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Oflamk MZ Oral Suspension Mango :
Remain calm. Administer the medication upon recollection unless your pediatrician has prescribed an alternate schedule. If the next dose is imminent, omit the missed dose. For any uncertainty, contact your doctor; avoid doubling the dose to compensate.
Facts to Know About Oflamk MZ Oral Suspension Mango
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
